FDA Adverse Event Death Summary report: N

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 3140091 · Received May 31, 2013

Report

Report Number
2024168-2013-03403
Event Type
Death
Date Received
May 31, 2013
Date of Event
March 3, 2013
Report Date
May 7, 2013
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. IN THIS CASE, THERE WERE NO REPORTED PRODUCT DEFICIENCIES. THE REPORTED PATIENT EFFECT OF DEATH IS LISTED IN THE PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM INSTRUCTIONS FOR USE AS A KNOWN PATIENT EFFECT. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECT AND THE RELATIONSHIP TO THE DEVICE IF ANY CANNOT BE DETERMINED, THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE, DESIGN, OR LABELING. YOU ARE RECEIVING THIS MDR REPORT FROM ABBOTT VASCULAR BECAUSE BOSTON SCIENTIFIC CORPORATION DISTRIBUTES PROMUS AS ITS OWN BRAND LABELING OF ABBOTT VASCULAR'S DRUG ELUTING STENT IN THE US.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2011, THE PROCEDURE WAS TO TREAT AN 80-85 % STENOSED LESION IN THE DISTAL CIRCUMFLEX. PRE-DILATATION WAS PERFORMED AND THE 2.5 X 12 MM PROMUS STENT WAS IMPLANTED WITH 0% STENSOSIS. ON (B)(6) 2013, THE PATIENT DIED AT A SKILLED NURSING FACILITY DUE TO CONGESTIVE HEART FAILURE. IT WAS NOTED THAT THE PATIENT WAS OFF OF THE ANTI-PLATELET THERAPY SINCE (B)(6) 2012. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
241351 PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 0081161

Patients

Seq Age Sex Outcome Treatment
1 71 YR Death